Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 403

1.

The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.

Dong C, Dai X, Meng JH.

Vaccine. 2007 Feb 19;25(9):1662-8. Epub 2006 Nov 13.

PMID:
17156900
2.

[Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio].

Dong C, Dai X, Meng JH.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Feb;23(2):130-3. Chinese.

PMID:
17286906
3.

Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.

Deshmukh TM, Lole KS, Tripathy AS, Arankalle VA.

Vaccine. 2007 May 30;25(22):4350-60. Epub 2007 Apr 9.

PMID:
17459540
4.

[Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].

Zhao YL, Chen YG, Li J, Han GX, Tian C, Liang JL, Li G, Wang ZG, Zhu YG, Tian ZN, Zhang HY, Wan ZJ, Liang ZL, Bi SL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jun;25(6):470-3. Chinese.

PMID:
15231119
5.

Development of candidate combination vaccine for hepatitis E and hepatitis B: a liposome encapsulation approach.

Shrivastava S, Lole KS, Tripathy AS, Shaligram US, Arankalle VA.

Vaccine. 2009 Nov 5;27(47):6582-8. doi: 10.1016/j.vaccine.2009.08.033. Epub 2009 Sep 9.

PMID:
19747579
6.

Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.

Knöll A, Hottenträger B, Kainz J, Bretschneider B, Jilg W.

Vaccine. 2000 Apr 3;18(19):2029-32.

PMID:
10706965
7.

Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.

Renoux VM, Fleury MJ, Bousarghin L, Gaitan J, Sizaret PY, Touzé A, Coursaget P.

Vaccine. 2008 Dec 2;26(51):6602-7. doi: 10.1016/j.vaccine.2008.09.035.

PMID:
18835319
8.

Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.

Arankalle VA, Lole KS, Deshmukh TM, Srivastava S, Shaligram US.

Vaccine. 2009 Feb 11;27(7):1032-9. doi: 10.1016/j.vaccine.2008.11.097. Epub 2008 Dec 16.

PMID:
19095027
9.

Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization.

Yang S, Wang C, Fang X, Zhai L, Dong C, Ding L, Meng J, Wang L.

Virus Res. 2010 Aug;151(2):162-9. doi: 10.1016/j.virusres.2010.04.011. Epub 2010 May 6.

PMID:
20451569
10.

Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine.

Abraham B, Baine Y, De-Clercq N, Tordeur E, Gerard PP, Manouvriez PL, Parenti DL.

Antiviral Res. 2002 Jan;53(1):63-73.

PMID:
11684316
11.

Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine.

Purcell RH, Nguyen H, Shapiro M, Engle RE, Govindarajan S, Blackwelder WC, Wong DC, Prieels JP, Emerson SU.

Vaccine. 2003 Jun 2;21(19-20):2607-15.

PMID:
12744897
12.

[Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].

Chlíbek R, Smetana J, Sindelár R, Cecetková B, Prymula R, Kohl I.

Epidemiol Mikrobiol Imunol. 2007 Aug;56(3):119-28. Czech.

PMID:
17900060
13.

[Results of Russian multicenter trial of immunogenicity, reactogenicity and safety of new combination vaccine against hepatitis A and B (Twinrix)].

Tatochenko VK, Il'ina NI, Romanenko VV, Alikova OA, Fassakhov RS, Miasnikova TN, Patlusova VV, Zima IuIu, Reshetnikova ID, Frolova GS, Smolenov IV.

Zh Mikrobiol Epidemiol Immunobiol. 2006 Sep-Oct;(6):30-5. Russian.

PMID:
17163135
14.

The expression, purification, and immunogenicity of a new chimeric virus-like particle.

Kui X, Sun M, Xie T, Wang W, Jiang L, Yan M, Ma K, Li H.

Viral Immunol. 2009 Feb;22(1):49-56. doi: 10.1089/vim.2008.0068.

PMID:
19210228
15.

Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection.

Kamili S, Spelbring J, Carson D, Krawczynski K.

J Infect Dis. 2004 Jan 15;189(2):258-64. Epub 2004 Jan 8.

PMID:
14722891
16.

[Immunogenecity of combined hepatitis A and B vaccine].

Shi L, Chu JY, Sun MB, Huang XQ, Yu JK, Li CY, Sun H, Yu L.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Apr;26(2):155-9. Chinese.

PMID:
15171552
17.

Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells.

Zhang M, Emerson SU, Nguyen H, Engle RE, Govindarajan S, Gerin JL, Purcell RH.

Vaccine. 2001 Dec 12;20(5-6):853-7.

PMID:
11738749
18.
19.

Specific memory B cell response and participation of CD4+ central and effector memory T cells in mice immunized with liposome encapsulated recombinant NE protein based Hepatitis E vaccine candidate.

Kulkarni SP, Thanapati S, Arankalle VA, Tripathy AS.

Vaccine. 2016 Nov 21;34(48):5895-5902. doi: 10.1016/j.vaccine.2016.10.046. Epub 2016 Oct 27.

PMID:
27997340
20.

Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?

Kallinowski B, Knöll A, Lindner E, Sänger R, Stremmel W, Vollmar J, Zieger B, Jilg W.

Vaccine. 2000 Aug 15;19(1):16-22.

PMID:
10924782

Supplemental Content

Support Center